论文部分内容阅读
目的:探讨罗库溴铵在饱胃病人快诱导插管中的应用。方法:将60例急诊饱胃患者随机分为A组(罗库溴铵组)和B组(维库溴铵组)。A组患者给予罗库溴铵,剂量为0.9mg/kg;B组患者给予维库溴铵,剂量为0.15mg/kg;诱导完成后根据Cooper表进行评分,同时记录两组患者于入室时(T1)、诱导后插管前(T2)、插管完成后3min(T3)共三个时间窗的收缩压(SBP)、舒张压(DBP)、心率(HR)以及不良反应发生的情况。结果:在排除人为因素后,罗库溴铵组具有更低的二次插管率。罗库溴铵对心血管系统的影响以及呛咳的发生率明显低于维库溴铵组。结论:罗库溴铵对饱胃患者快诱导插管中更具有优势。
Objective: To investigate the application of rocuronium in rapid induction catheterization in patients with full stomach. Methods: Sixty patients with acute gastric insufficiency were randomly divided into group A (rocuronium bromide group) and group B (vecuronium group). Patients in group A were given rocuronium at a dose of 0.9 mg / kg; patients in group B were given vecuronium at a dose of 0.15 mg / kg; scores were scored on the Cooper scale after induction, (SBP), diastolic blood pressure (DBP), heart rate (HR) and adverse reactions in three time windows of T1, T2, T3 and T3 after intubation. RESULTS: After excluding human factors, the rocuronium group had a lower rate of secondary intubation. The impact of rocuronium on the cardiovascular system and the incidence of cough was significantly lower than the vecuronium group. CONCLUSION: Rocuronium is more effective in rapidly inducing intubation in patients with full stomach.